Dimed S.A. Distribuidora de Medicamentos (PNVL3) Ratios
Dimed S.A. Distribuidora de Medicamentos Ratios
BR:PNVL3's free cash flow for Q2 2026 was R$62.56M. For the 2026 fiscal year, BR:PNVL3's free cash flow was decreased by R$-27.20M and operating cash flow was R$89.76M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.74 | 1.70 | 1.62 | 1.55 | 1.71 |
| Quick Ratio | 0.86 | 0.73 | 0.74 | 0.66 | 0.80 |
| Cash Ratio | 0.03 | 0.07 | 0.02 | 0.03 | 0.07 |
| Solvency Ratio | 0.14 | 0.15 | 0.15 | 0.17 | 0.18 |
| Operating Cash Flow Ratio | 0.32 | 0.19 | 0.26 | 0.20 | 0.16 |
| Short-Term Operating Cash Flow Coverage | 2.20 | 1.38 | 2.89 | 1.74 | 2.41 |
| Net Current Asset Value | R$ -251.07M | R$ -130.16M | R$ -63.99M | R$ -66.42M | R$ 60.22M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.39 | 0.37 | 0.33 | 0.32 | 0.29 |
| Debt-to-Equity Ratio | 1.18 | 1.00 | 0.87 | 0.79 | 0.66 |
| Debt-to-Capital Ratio | 0.54 | 0.50 | 0.47 | 0.44 | 0.40 |
| Long-Term Debt-to-Capital Ratio | 0.29 | 0.24 | 0.19 | 0.10 | 0.07 |
| Financial Leverage Ratio | 2.99 | 2.74 | 2.62 | 2.47 | 2.28 |
| Debt Service Coverage Ratio | 1.36 | 1.52 | 1.93 | 1.78 | 2.99 |
| Interest Coverage Ratio | 1.72 | 1.71 | 1.62 | 1.88 | 2.77 |
| Debt to Market Cap | 0.40 | 0.42 | 0.20 | 0.17 | 0.07 |
| Interest Debt Per Share | 11.04 | 9.05 | 7.57 | 6.36 | 4.87 |
| Net Debt to EBITDA | 3.11 | 2.70 | 2.52 | 2.54 | 2.29 |
| Profitability Margins | |||||
| Gross Profit Margin | 28.17% | 31.79% | 30.87% | 31.14% | 30.65% |
| EBIT Margin | 4.32% | 4.40% | 4.35% | 3.72% | 3.73% |
| EBITDA Margin | 8.54% | 8.65% | 8.84% | 8.35% | 8.62% |
| Operating Profit Margin | 4.32% | 3.95% | 3.73% | 3.44% | 3.19% |
| Pretax Profit Margin | 2.64% | 2.28% | 2.05% | 1.97% | 2.58% |
| Net Profit Margin | 2.26% | 2.13% | 2.08% | 2.16% | 2.46% |
| Continuous Operations Profit Margin | 2.26% | 2.13% | 2.08% | 2.16% | 2.46% |
| Net Income Per EBT | 85.62% | 93.73% | 101.44% | 110.09% | 95.42% |
| EBT Per EBIT | 61.08% | 57.64% | 54.98% | 57.13% | 80.85% |
| Return on Assets (ROA) | 3.25% | 3.12% | 3.02% | 3.16% | 3.34% |
| Return on Equity (ROE) | 9.72% | 8.55% | 7.92% | 7.79% | 7.59% |
| Return on Capital Employed (ROCE) | 9.49% | 8.91% | 8.57% | 7.96% | 6.57% |
| Return on Invested Capital (ROIC) | 7.19% | 7.36% | 7.54% | 6.88% | 5.60% |
| Return on Tangible Assets | 3.35% | 3.22% | 3.10% | 3.25% | 3.42% |
| Earnings Yield | 6.97% | 8.04% | 4.95% | 6.34% | 4.32% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.87 | 8.55 | 7.96 | 8.59 | 8.07 |
| Payables Turnover | 5.46 | 5.34 | 4.54 | 4.95 | 4.81 |
| Inventory Turnover | 3.39 | 2.93 | 3.09 | 3.07 | 3.03 |
| Fixed Asset Turnover | 4.13 | 4.21 | 4.13 | 3.86 | 3.69 |
| Asset Turnover | 1.44 | 1.46 | 1.45 | 1.46 | 1.35 |
| Working Capital Turnover Ratio | 6.11 | 6.45 | 7.10 | 7.06 | 5.04 |
| Cash Conversion Cycle | 87.04 | 99.06 | 83.68 | 87.81 | 89.97 |
| Days of Sales Outstanding | 46.36 | 42.69 | 45.85 | 42.51 | 45.20 |
| Days of Inventory Outstanding | 107.55 | 124.67 | 118.29 | 119.08 | 120.60 |
| Days of Payables Outstanding | 66.87 | 68.30 | 80.46 | 73.78 | 75.83 |
| Operating Cycle | 153.91 | 167.36 | 164.14 | 161.59 | 165.80 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.83 | 1.51 | 1.99 | 1.38 | 0.88 |
| Free Cash Flow Per Share | 2.01 | 0.45 | 1.06 | 0.16 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | 2.84 | 1.18 | 1.76 | 1.00 | 0.84 |
| Capital Expenditure Coverage Ratio | 3.45 | 1.42 | 2.13 | 1.13 | 0.97 |
| Operating Cash Flow Coverage Ratio | 0.28 | 0.18 | 0.29 | 0.24 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.05 | 0.07 | 0.05 | 0.04 |
| Free Cash Flow Yield | 16.74% | 5.08% | 8.38% | 1.75% | -0.24% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 14.27 | 12.39 | 20.18 | 15.76 | 23.15 |
| Price-to-Sales (P/S) Ratio | 0.32 | 0.27 | 0.42 | 0.34 | 0.57 |
| Price-to-Book (P/B) Ratio | 1.39 | 1.06 | 1.60 | 1.23 | 1.76 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.97 | 19.70 | 11.93 | 57.08 | -417.65 |
| Price-to-Operating Cash Flow Ratio | 4.24 | 5.85 | 6.32 | 6.62 | 14.02 |
| Price-to-Earnings Growth (PEG) Ratio | 0.78 | 0.85 | 2.93 | 1.67 | 0.54 |
| Enterprise Value Multiple | 6.90 | 5.77 | 7.28 | 6.63 | 8.90 |
| Enterprise Value | 3.25B | 2.47B | 2.87B | 2.21B | 2.47B |
| EV to EBITDA | 6.90 | 5.77 | 7.28 | 6.63 | 8.90 |
| EV to Sales | 0.59 | 0.50 | 0.64 | 0.55 | 0.77 |
| EV to Free Cash Flow | 10.86 | 37.04 | 18.26 | 92.55 | -562.24 |
| EV to Operating Cash Flow | 7.71 | 11.00 | 9.68 | 10.74 | 18.87 |
| Tangible Book Value Per Share | 7.87 | 7.63 | 7.33 | 6.94 | 6.59 |
| Shareholders’ Equity Per Share | 8.60 | 8.28 | 7.89 | 7.46 | 6.99 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.14 | 0.06 | -0.01 | -0.10 | 0.05 |
| Revenue Per Share | 36.98 | 33.15 | 30.00 | 26.86 | 21.56 |
| Net Income Per Share | 0.84 | 0.71 | 0.62 | 0.58 | 0.53 |
| Tax Burden | 0.86 | 0.94 | 1.01 | 1.10 | 0.95 |
| Interest Burden | 0.61 | 0.52 | 0.47 | 0.53 | 0.69 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.08 | 0.06 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 3.38 | 2.13 | 3.19 | 2.38 | 1.65 |
Currency in BRL
